Table of Contents
Pharma Manufacturing
Starting Point
Improving the Economics of Compliance
Our Business Environment - Tough & Getting Tougher
Shareholder Returns - Falling
R&D Productivity - Falling
Window of Exclusivity - Decreasing
Pharma Manufacturing - Unmet Performance Expectations
Conclusions
Our Findings - Problems Start in Development
Three Keys to Unlocking the Potential for Improvement
EXAMPLE: Value Added -vs- Non Value Added Process Time
EXAMPLE: See It to Fix It - Value-Added Time Only 3 Days!
Measurement Shows Potential for Improvement
EXAMPLE: Traditional MRP II Measurement - For Accountants.
EXAMPLE: Measuring for Productivity - Reveals Potential
EXAMPLE: Sigma - Getting it Right First Time.
Measure Process Spread & Variability
Calculating The Purely Business Benefits
A Thought Experiment - 5 Sigma Pharmaceutical Production
Benefits - Increased Effectiveness of Compliance Infrastructure
Summary
PPT Slide
|